Skip to content
User

Henry Ellenbogen

Durable Capital Partners

Henry Ellenbogen Molina Healthcare Inc stake

total: 158

Durable Capital Partners MOH trades

Total transactions:
15
New positions:
1
Sold out:
1
Added:
8
Reduced:
5
Held since:
2022 Q1
Held for:
14 quarters
Latest activity:
2025 Q3
According to 2026 Q2 report, Henry Ellenbogen doesn't hold any Molina Healthcare Inc (MOH) shares. To date, the estimated cost basis is nearly $322.39 for "buy" trades and estimated average "sell" price is $325.54. Durable Capital Partners first purchased MOH in 2022 Q1, initially acquiring 642,594 shares. Since the initial investment in Molina Healthcare Inc (MOH), Durable Capital Partners has made 14 more transactions.

When did Henry Ellenbogen sell Molina Healthcare Inc (MOH)?

Henry Ellenbogen sold off the entire Molina Healthcare Inc (MOH) position in 2025 Q3.

When did Henry Ellenbogen buy Molina Healthcare Inc (MOH)?

Henry Ellenbogen first invested in Molina Healthcare Inc (MOH) in 2022 Q1 at the reported quarter-end price of $333.59 per share.

What's the cost basis of Durable Capital Partners's MOH stake?

The estimated cost basis for Molina Healthcare Inc (MOH) stake is around $322.39 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$322.39
Weighted AVG sell price:
$325.54

Henry Ellenbogen's historical trades in Molina Healthcare Inc

15 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q3
0.00%
0
$297.90
-100% (-535,967)
-1.21%
2025 Q2
1.21%
535,967
$297.90
$159,664,569
-1.04% (-5,638)
-0.02%
2025 Q1
1.59%
541,605
$329.39
$178,399,271
+13.14% (+62,899)
+0.19%
2024 Q4
1.14%
478,706
$291.05
$139,327,381
-54.37% (-570,456)
-1.21%
2024 Q3
2.64%
1,049,162
$344.56
$361,499,259
+61.08% (+397,835)
+1%
2024 Q2
1.59%
651,327
$297.30
$193,639,517
-25.01% (-217,173)
-0.5%
2024 Q1
2.76%
868,500
$410.83
$356,805,855
-26.90% (-319,643)
-1.04%
2023 Q4
3.39%
1,188,143
$361.31
$429,287,947
-24.13% (-377,896)
-1.25%
2023 Q3
4.69%
1,566,039
$327.89
$513,488,528
+10.29% (+146,138)
+0.44%
2023 Q2
3.75%
1,419,901
$301.24
$427,730,977
+4.54% (+61,709)
+0.16%
2023 Q1
3.41%
$267.49
+9.53% (+118,147)
2022 Q4
4.26%
$330.22
+9.74% (+110,068)
2022 Q3
4.10%
$329.84
+22.77% (+209,584)
2022 Q2
2.95%
$279.61
+43.23% (+277,799)
2022 Q1
1.88%
$333.59
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.